Cerebrospinal Fluid Biomarkers Mirror Rate of Cognitive Decline
The DOI matches its Crossref record.
Abstract
The ability to predict future decline in cognitive systems using the cerebrospinal fluid (CSF) biomarkers 42 amino acid form of amyloid-β (Aβ 42 ) and total tau (T-tau) is not fully understood. In a clinical sample ranging from cognitively healthy to dementia (n = 326), linear regression models were performed in order to investigate the ability of CSF biomarkers to predict cognitive decline in all cognitive domains from baseline to 2-year follow-up. Gender, age, and years of education were included as covariates. In patients with subjective cognitive impairment, T-tau had a small impact on executive functions (r 2 = 0.07). T-tau had a small to moderate influence (r 2 = 0.06–0.11) on all cognitive functions with the exception of visuospatial functions in patients with mild cognitive impairment (MCI). In patients with dementia, the impact of T-tau was large (r 2 = 0.29) on semantic memory. Aβ 42 had a small effect (r 2 = 0.07) on speed and executive functions in MCI. In patients with dementia, Aβ 42 had a moderate influence (r 2 = 0.13–0.24) on semantic and verbal working memory/fluency. Our results speak in favor of the notion that CSF biomarkers reflect the rate of cognitive decline across the continuum of cognitive impairment from healthy to dementia. CSF predicted subsequent decline in more cognitive domains among MCI cases, but the impact was most pronounced in patients with dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
PET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
“Tau rather than A β pathology has also been shown to be closely related to cognition, predominantly memory decline, in post mortem studies of both aging and AD (Arriagada et al., 1992; Ghoshal et al., 2002; Mitchell et al., 2002; Nelson et al., 2012; Rolstad et al., 2013; van Rossum et al., 2012).”
InfluentialTau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., O’Neil, J. P., Janabi, M., Lazaris, A., Cantwell, A., et al. (2016) · Brain · doi:10.1093/brain/aww027 · Cited by 1,185
Pike, K. E., Cavuoto, M. G., Li, L., Wright, B. J., & Kinsella, G. J. (2022) · Neuropsychology Review · doi:10.1007/s11065-021-09522-3 · Cited by 259
Cheng, Y.-W., Chen, T.-F., & Chiu, M.-J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s123428 · Cited by 150
“While van Harten et al reported that low Aβ 42 was the strongest predictor of conversion to MCI or AD,(71) Hessen et al and Rolstad et al found that high t-tau rather than Aβ 42 was correlated with future decline in memory and executive functions.(72,73) Visser et al failed to find a significant association between ab…”
Preclinical AD predicts decline in memory and executive functions in subjective complaints
van Harten, A. C., Smits, L. L., Teunissen, C. E., Visser, P. J., Koene, T., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a8418b · Cited by 143
Metadata
- Authors
- Rolstad, S., Berg, A. I., Bjerke, M., Johansson, B., Zetterberg, H., & Wallin, A.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2013-03-20
- Volume
- 34
- Issue
- 4
- Pages
- 949-956
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1705785002
- Cited by
- 38
- References
- 0
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrospinal Fluid Biomarkers Mirror Rate of Cognitive Decline. https://app.cochat.ai/papers/10.3233/jad-121960
- The paper
- Rolstad, S., Berg, A. I., Bjerke, M., Johansson, B., Zetterberg, H., & Wallin, A. (2013). Cerebrospinal Fluid Biomarkers Mirror Rate of Cognitive Decline. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-121960
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.